Global Ketoprofen Market Growth 2023-2029

Global Ketoprofen Market Growth 2023-2029

Ketoprofen is a nonsteroidal anti-inflammatory drug with analgesic and antipyretic effects. It is used to relieve the signs and symptoms of rheumatoid arthritis and osteoarthritis. It is also used to relieve mild to moderate pain, as well as menstrual pain.

In this research the statistics are Ketoprofen BPC (bulk pharmaceutical chemicals).

LPI (LP Information)' newest research report, the “Ketoprofen Industry Forecast” looks at past sales and reviews total world Ketoprofen sales in 2022, providing a comprehensive analysis by region and market sector of projected Ketoprofen sales for 2023 through 2029. With Ketoprofen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ketoprofen industry.

This Insight Report provides a comprehensive analysis of the global Ketoprofen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ketoprofen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Ketoprofen market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ketoprofen and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ketoprofen.

The global Ketoprofen market size is projected to grow from US$ 34 million in 2022 to US$ 39 million in 2029; it is expected to grow at a CAGR of 39 from 2023 to 2029.

China is the largest Ketoprofen market with about 68% market share. Europe is follower, accounting for about 18% market share.

The key players are SANOFI-Aventis, Boehringer-Ingelheim, BEC, Zhejiang Jiuzhou, Hubei Xunda etc. Top 3 companies occupied about 83% market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Ketoprofen market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Ketoprofen above 99.5%

Ketoprofen below 99.5%

Segmentation by application

Ketoprofen Tablets

Ketoprofen Capsules

Ketoprofen Gel

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

SANOFI-Aventis

Boehringer-Ingelheim

BEC

Zhejiang Jiuzhou

Hubei Xunda

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ketoprofen market?

What factors are driving Ketoprofen market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ketoprofen market opportunities vary by end market size?

How does Ketoprofen break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.